Mandate

Vinge advises Com Hem in connection with its application for listing on NASDAQ OMX Stockholm

June 03, 2014


Following the announcement of its intention to float on May 23, 2014, Com Hem Holding AB (publ) (“Com Hem”), a leading provider of TV, broadband and fixed telephony services in Sweden, has today published a prospectus and announced the price range for the initial public offering of its shares and its listing on NASDAQ OMX Stockholm. Vinge advises Com Hem in connection with the listing.
 
The Company will raise gross proceeds of up to SEK 6.24 billion in the initial public offering.
 
Vinge’s team primarily consists of partners Peter Bäärnhielm and Jesper Schönbeck and associates David Andersson, Joakim Hagberg, Sabina Börjesson, Charlotta Järnstedt and Tora Hansjons.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026